Empire Life Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-74,397
Closed -$4.94M 114
2025
Q4
$4.94M Sell
74,397
-927
-1% -$59.9K 0.28% 70
2025
Q3
$5.07M Buy
75,324
+494
+0.7% +$39.1K 0.3% 71
2025
Q2
$6.53M Sell
74,830
-7,378
-9% -$578K 0.41% 64
2025
Q1
$5.61M Sell
82,208
-7,055
-8% -$576K 0.37% 68
2024
Q4
$6.94M Buy
89,263
+5,537
+7% +$410K 0.44% 61
2024
Q3
$5.61M Buy
+83,726
New +$6.88M 0.34% 64

Other funds holding DXCM

Empire Life Investments's DXCM Position: Q1 2026 in Review

Empire Life Investments sold out of DexCom (DXCM) in Q1 2026, closing a stake of 74,397 shares — an estimated $4.94M sold.

Empire Life Investments first reported a position in DXCM in Q3 2024 and held it in 6 quarters. The position peaked at $6.94M in Q4 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Empire Life Investments reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Empire Life Investments sold 74,397 DexCom shares in Q1 2026, an estimated $4.94M.
  • Empire Life Investments first reported a position in DexCom in Q3 2024 and held it in 6 quarters.
  • Empire Life Investments's DexCom position peaked at $6.94M in Q4 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Empire Life Investments's 13F filing for Q1 2026, filed 11 May 2026.